Regeneron Pharmaceuticals Inc: All Recent News

• All recent news
• Earnings news

4 Platform Drugmakers to Invest In 11/24/2009

No special shoes required. At Motley Fool

Regeneron Announces Presentation at the 21st Annual Piper... 11/24/2009

TARRYTOWN, N.Y., Nov. 24 /PRNewswire-FirstCall/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) will webcast its presentation at the 21st Annual Piper Jaffray Healthcare Conference on Tuesday,... PR Newswire

Now That's What I Call a Drug Deal 11/11/2009

Regenerating interest in Regeneron. At Motley Fool

Sanofi's Research Shift: Billion-Dollar Deal, Venture Capital Fund 11/11/2009

... At Wall Street Journal

Sanofi-Aventis, Regeneron expand antibody efforts 11/11/2009

TEL AVIV (MarketWatch) -- Sanofi-Aventis, the Paris health-care giant, and Regeneron Pharmaceuticals Inc., the Tarrytown, N.Y., biopharmaceutical producer, expanded their effort to discover and market therapeutic monoclonal antibodies. Within the deal, Sanofi-Aventis will boost its funding commitment to $160 million a year from $100 million beginning in 2010. The funding commitment will now extend through 2017; the venture had been set to expire at the end of 2012. The companies aim to bring as many as five antibodies into clinical development each year, they said in a statement late on... At MarketWatch

Sanofi-Aventis, Regeneron extend development deal 11/10/2009

NEW YORK (AP) - Sanofi-Aventis and Regeneron Pharmaceuticals Inc. said Tuesday they expanded an existing development partnership to run through 2017. Associated Press

Regeneron Announces Conference Call to Discuss Expanded... 11/10/2009

TARRYTOWN, N.Y., Nov. 10 /PRNewswire-FirstCall/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) will host a conference call and live webcast at 8:30 a.m. Eastern Time on Wednesday, November 11 to... PR Newswire

Market Report -- In Play (REGN) 11/10/2009

Regeneron Pharms and Sanofi-aventis expand strategic antibody collaboration The co and SNY announce that they have entered into agreements to expand and extend their existing global collaboration to... Briefing.com

Sanofi-aventis and Regeneron Expand Strategic Antibody... 11/10/2009

- New agreements expand and extend November 2007 antibody collaboration- Collaboration goal is to advance 4 to 5 antibodies per year into clinical development- Sanofi-aventis to fund up to $160M... PR Newswire

Regeneron Reports Third Quarter 2009 Financial and Operating... 11/3/2009

TARRYTOWN, N.Y., Nov. 3 /PRNewswire-FirstCall/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN)today announced financial and operating results for the third quarter of 2009. The Company reported a... PR Newswire

Regeneron's Rilonacept Granted European Marketing... 10/27/2009

TARRYTOWN, N.Y., Oct. 27 /PRNewswire-FirstCall/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today announced it has received marketing authorization in the European Union for rilonacept, an... PR Newswire

Regeneron Announces Presentation at the 18th Annual Credit... 10/27/2009

TARRYTOWN, N.Y., Oct. 27 /PRNewswire-FirstCall/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) will webcast its presentation at the 18th Annual Credit Suisse Healthcare Conference on Wednesday,... PR Newswire

More News

Market Report

News by Symbol

Today's Investing Articles

Breaking News

News by Topic

News by Industry

MSNBC News

MSN Money

Search MSN Money

Message Boards

Site Status